Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2019 07:30 ET | Source: VIVUS, Inc.

VIVUS Announces Approval of Qsymia® in the Republic of Korea

VIVUS receives $2.5 million milestone payment CAMPBELL, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, announced today that its...
July 23, 2019 07:30 ET | Source: VIVUS, Inc.

VIVUS to Host Second Quarter Business Update and Financial Results Conference Call on Tuesday, August 6, 2019

CAMPBELL, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report financial results and provide a business update for the second quarter of 2019...
June 26, 2019 16:05 ET | Source: VIVUS, Inc.

VIVUS and Nordmark Amend Contract Manufacturing Agreement to Supply Current and Future Demand for PANCREAZE®

-Companies will also collaborate to develop additional PANCREAZE dose formulations and an advanced formulation with an extended shelf life- CAMPBELL, Calif., June 26, 2019 (GLOBE NEWSWIRE) -- ...
June 11, 2019 07:30 ET | Source: VIVUS, Inc.

VIVUS Reduces Barrier to Achieving Healthy Weight Goals With Launch of Online Platform to Purchase Qsymia®

A 30% plus reduction in patient out of pocket expense for medication, on-line purchasing and direct home delivery better enable patients to initiate and maintain Qsymia therapy CAMPBELL, Calif.,...
May 28, 2019 07:30 ET | Source: VIVUS, Inc.

VIVUS Initiates Phase Four Safety and Efficacy Study of Qsymia® in Obese Adolescents

-Post-marketing study designed to evaluate Qsymia as an approach to weight management in a growing patient population with significant unmet medical need- CAMPBELL, Calif., May 28,...